Yuexin Xu

3PUBLICATIONS
16CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|May 30, 2024
Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses.

Edward L Briercheck, Shashidhar Ravishankar, Elshafa Hassan Ahmed

|Mar 05, 2021
Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma.

Yuexin Xu, Chris P Miller, Edus H Warren

|Nov 06, 2019
Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.

Yuexin Xu, Alicia J Morales, Michael J Cargill

Pageof 1

Frequent Collaborators

2 joint publications

Edus H Warren

1 joint publications

Scott S Tykodi

1 joint publications

Edward L Briercheck

1 joint publications

Shashidhar Ravishankar

1 joint publications

Elshafa Hassan Ahmed

1 joint publications

César Camilo Carías Alvarado

1 joint publications

Juan Carlos Barrios Menéndez

1 joint publications

Oscar Silva

1 joint publications

Anthony Wilder Wohns

1 joint publications

Carlos Barrionuevo

Frequent Collaborators

2 joint publications

Edus H Warren

1 joint publications

Scott S Tykodi

1 joint publications

Edward L Briercheck

1 joint publications

Shashidhar Ravishankar

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on : Sep 28, 2022

3.9K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on : Feb 14, 2025

1.4K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

1.2K
See more related videos

Top Related Videos

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on : Sep 28, 2022

3.9K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on : Feb 14, 2025

1.4K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

1.2K
See more related videos